Your browser doesn't support javascript.
loading
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes, Renato D; Macedo, Ariane Vieira Scarlatelli; de Barros E Silva, Pedro Gabriel Melo; Moll-Bernardes, Renata Junqueira; Feldman, Andre; D'Andréa Saba Arruda, Guilherme; de Souza, Andrea Silvestre; de Albuquerque, Denilson Campos; Mazza, Lilian; Santos, Mayara Fraga; Salvador, Natalia Zerbinatti; Gibson, C Michael; Granger, Christopher B; Alexander, John H; de Souza, Olga Ferreira.
Afiliación
  • Lopes RD; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Brazilian Clinical Research Institute, São Paulo, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil. Electronic address: renato.lopes@dm.duk
  • Macedo AVS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil; Santa Casa de São Paulo, São Paulo, Brazil.
  • de Barros E Silva PGM; Brazilian Clinical Research Institute, São Paulo, Brazil.
  • Moll-Bernardes RJ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
  • Feldman A; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil.
  • D'Andréa Saba Arruda G; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil.
  • de Souza AS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • de Albuquerque DC; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
  • Mazza L; Brazilian Clinical Research Institute, São Paulo, Brazil.
  • Santos MF; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
  • Salvador NZ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
  • Gibson CM; Harvard Medical School, Boston, MA, USA.
  • Granger CB; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Alexander JH; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • de Souza OF; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil.
Am Heart J ; 226: 49-59, 2020 08.
Article en En | MEDLINE | ID: mdl-32502882
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Inhibidores de la Enzima Convertidora de Angiotensina / Infecciones por Coronavirus / Antagonistas de Receptores de Angiotensina / Ensayos Clínicos Pragmáticos como Asunto / Betacoronavirus Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: Am Heart J Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Inhibidores de la Enzima Convertidora de Angiotensina / Infecciones por Coronavirus / Antagonistas de Receptores de Angiotensina / Ensayos Clínicos Pragmáticos como Asunto / Betacoronavirus Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: Am Heart J Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos